Exact Sciences Cor (EXAS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2023 | 12-2022 | 12-2021 | 12-2020 | 12-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 605,378 | 242,493 | 315,471 | 1,491,288 | 177,254 |
| Marketable Securities | 172,266 | 389,564 | 715,005 | 348,699 | 146,401 |
| Receivables | 203,623 | 158,043 | 216,645 | 233,185 | 130,362 |
| Inventories | 127,475 | 118,259 | 104,994 | 92,265 | 61,724 |
| TOTAL | $1,194,369 | $982,257 | $1,426,237 | $2,198,594 | $553,936 |
| Non-Current Assets | |||||
| PPE Net | 698,354 | 684,756 | 580,248 | 451,986 | 455,325 |
| Intangibles | 4,257,516 | 4,302,280 | 4,429,583 | 2,084,795 | 2,346,747 |
| Other Non-Current Assets | 321,095 | 257,580 | 248,816 | 189,717 | 149,760 |
| TOTAL | $5,276,965 | $5,244,616 | $5,258,647 | $2,726,498 | $2,951,832 |
| Total Assets | $6,471,334 | $6,226,873 | $6,684,884 | $4,925,092 | $3,505,768 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 50,000 | 0 | N/A | 314,034 | 834 |
| Accounts payable and accrued liabilities | 78,816 | 74,916 | 67,829 | 35,709 | 25,973 |
| Accrued Expenses | 341,683 | 299,216 | 398,556 | 233,604 | 193,329 |
| Other current liabilities | 14,823 | 10,249 | 30,973 | 38,265 | 8,467 |
| TOTAL | $514,701 | $412,747 | $517,068 | $633,095 | $236,494 |
| Non-Current Liabilities | |||||
| Long Term Debt | 0 | 50,000 | N/A | 22,342 | 24,032 |
| Other Non-Current Liabilities | 2,811,328 | 2,720,964 | 2,780,180 | 2,034,102 | 957,181 |
| TOTAL | $2,811,328 | $2,770,964 | $2,780,180 | $2,056,444 | $981,213 |
| Total Liabilities | $3,326,029 | $3,183,711 | $3,297,248 | $2,689,539 | $1,217,707 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 181,531 | 178,217 | 174,117 | 169,093 | 147,968 |
| Common Shares | 1,815 | 1,780 | 1,738 | 1,595 | 1,477 |
| Retained earnings | -3,469,175 | -3,265,026 | -2,641,520 | -2,045,895 | -1,119,756 |
| Other shareholders' equity | 1,428 | -5,236 | -1,443 | 526 | -100 |
| TOTAL | $3,145,305 | $3,043,162 | $3,387,636 | $2,235,553 | $2,288,061 |
| Total Liabilities And Equity | $6,471,334 | $6,226,873 | $6,684,884 | $4,925,092 | $3,505,768 |